Cooper Companies, Inc. (COO)

Sector: Healthcare
Industry: Ophthalmic Goods
Country: United States
Exchange: NASDAQ
Market cap: $11.47B
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Latest financial period: July 31, 2026
Filed with the SEC: September 9, 2026
Estimated earnings date: December 3, 2026
Profit #1057 of 1422 companies
| | Jul 26 | Apr 26 | Jan 26 | Oct 25 |
|---|
| ROIC | 4.9% | 3.6% | 4.5% | 4.4% |
Growth #808 of 1422 companies
Payout #633 of 1422 companies
Safety #107 of 1422 companies
Price #487 of 1422 companies